gemcitabine has been researched along with cytochrome c-t in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (37.50) | 29.6817 |
2010's | 10 (62.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Christgen, M; Haye, S; Kalthoff, H; Kremer, B; Kurdow, R; Schniewind, B; Ungefroren, H | 1 |
Ashley, SW; Benoit, E; Duxbury, MS; Ito, H; Waseem, T; Whang, EE | 1 |
Alsina, M; Beam, C; Beaupre, DM; Dalton, W; Gerbino, E; Hamilton, AD; Kerr, WG; Lichtenheld, MG; Mackley, PA; Muro-Cacho, C; Sebti, SM; Zhu, K | 1 |
Braconi, C; Henson, R; Lang, M; Patel, T | 1 |
Banerjee, S; Kong, D; Sarkar, FH; Wang, Z | 1 |
Banerjee, S; Kaseb, AO; Kong, D; Mohammad, M; Mohammad, RM; Padhye, S; Sarkar, FH; Wang, Z | 1 |
Sun, Q; Yu, J; Zhang, L; Zheng, X | 1 |
Chen, H; Guo, Y; Lin, S; Liu, A; Liu, J; Tan, W; Tong, H; Wang, Z; Wei, W | 1 |
Chen, H; Guo, H; Guo, Y; Lin, S; Liu, D; Wei, W | 1 |
Arnoletti, JP; Chen, Y; Jhala, NC; Jing, G; McDonald, JM; Turk, AN; Yuan, K; Zhang, K | 1 |
Chen, CY; Huang, AM; Li, JH; Liu, CH | 1 |
Cui, K; Li, L; Li, S; Niu, ZX; Sun, ZQ; Tian, H; Wang, AL; Wang, CL; Xue, Y; Zhang, B; Zhao, B; Zhou, WY | 1 |
Beckham, TH; Beeson, CC; Beeson, G; Bielawska, A; Bielawski, J; Cheng, JC; Drake, RR; Jones, EE; Lewis, CS; Liu, X; Lu, P; Marrison, T; Norris, JS; Ogretmen, B; Ramshesh, VK; Szulc, ZM | 1 |
Bao, GQ; Pan, CP; Peng, CH; Shen, BY; Shi, MM; Zhang, YJ | 1 |
Chen, MC; Eibl, G; Hines, OJ; Ishiguro, H; Matsuo, Y; Pham, H; Reber, HA; Takahashi, H; Takeyama, H | 1 |
Bu, HQ; Huang, H; Jin, HM; Li, Y; Liu, DL; Zhao, JF | 1 |
16 other study(ies) available for gemcitabine and cytochrome c-t
Article | Year |
---|---|
Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria-mediated apoptosis.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; BH3 Interacting Domain Death Agonist Protein; Carrier Proteins; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 8; Caspase 9; Caspases; Cytochromes c; Deoxycytidine; Drug Resistance, Neoplasm; fas Receptor; Female; Gemcitabine; Intracellular Signaling Peptides and Proteins; Membrane Potentials; Mice; Mice, Inbred BALB C; Mice, SCID; Mitochondria; Pancreatic Neoplasms; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Retroviridae; Tumor Cells, Cultured | 2004 |
A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells.
Topics: Adenocarcinoma; Antigens, CD; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Caspase 3; Caspases; Cell Adhesion Molecules; Cell Line, Tumor; CSK Tyrosine-Protein Kinase; Cytochromes c; Deoxycytidine; Drug Resistance, Viral; Enzyme Activation; Gemcitabine; Gene Silencing; GPI-Linked Proteins; Humans; Pancreatic Neoplasms; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; src-Family Kinases; Transfection | 2004 |
Farnesyltransferase inhibitor R115777 (Zarnestra, Tipifarnib) synergizes with paclitaxel to induce apoptosis and mitotic arrest and to inhibit tumor growth of multiple myeloma cells.
Topics: Alkyl and Aryl Transferases; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Bone Marrow Cells; Caspase 3; Caspases; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Proliferation; Cisplatin; Clinical Trials as Topic; Cytochromes c; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Enzyme Activation; Farnesyltranstransferase; Flow Cytometry; Fluorouracil; G2 Phase; Gemcitabine; Homozygote; Humans; In Situ Nick-End Labeling; Inhibitory Concentration 50; Mice; Mice, SCID; Mitosis; Multiple Myeloma; Paclitaxel; Quinolones; Taxoids; Tetrazolium Salts; Thiazoles | 2005 |
Epigallocatechin-gallate modulates chemotherapy-induced apoptosis in human cholangiocarcinoma cells.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Bile Duct Neoplasms; Blotting, Western; Camellia sinensis; Catechin; Cell Line, Tumor; Cholangiocarcinoma; Cytochromes c; Deoxycytidine; Fluorouracil; Gemcitabine; Humans; Immunohistochemistry; Membrane Potential, Mitochondrial; Mice; Mice, Nude; Mitomycin; Plant Extracts | 2009 |
3,3'-Diindolylmethane enhances chemosensitivity of multiple chemotherapeutic agents in pancreatic cancer.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Cisplatin; Cytochromes c; Deoxycytidine; Drug Synergism; Gemcitabine; Humans; Indoles; NF-kappa B; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms | 2009 |
Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoquinones; Caspases; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Survival; Cytochromes c; Deoxycytidine; Dinoprostone; Drug Synergism; Female; Gemcitabine; Humans; Mice; Mice, Inbred ICR; Mice, SCID; NF-kappa B; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms | 2009 |
Smac modulates chemosensitivity in head and neck cancer cells through the mitochondrial apoptotic pathway.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Biomimetic Materials; Blotting, Western; Caspase 3; Cell Line, Tumor; Cytochromes c; Deoxycytidine; Drug Synergism; Enzyme Activation; Female; Gemcitabine; Head and Neck Neoplasms; Humans; Intracellular Signaling Peptides and Proteins; Mice; Mice, Nude; Mitochondria; Mitochondrial Proteins; RNA Interference; Signal Transduction; Xenograft Model Antitumor Assays | 2011 |
Enhanced effect of gemcitabine by emodin against pancreatic cancer in vivo via cytochrome C-regulated apoptosis.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Deoxycytidine; Drug Synergism; Emodin; Female; Gemcitabine; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Xenograft Model Antitumor Assays | 2011 |
[Emodin enhances antitumor effect of gemcitabine in model of SW1990 cell xenograft on athymic mouse].
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Transformation, Neoplastic; Cytochromes c; Deoxycytidine; Drug Synergism; Emodin; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Proto-Oncogene Proteins c-bcl-2; Tumor Burden; Xenograft Model Antitumor Assays | 2010 |
Tamoxifen enhances therapeutic effects of gemcitabine on cholangiocarcinoma tumorigenesis.
Topics: Animals; Apoptosis; Blotting, Western; Caspases; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Cytochromes c; Deoxycytidine; Drug Therapy, Combination; Enzyme Activation; Gemcitabine; Immunohistochemistry; In Situ Nick-End Labeling; Mice; Mice, Nude; Tamoxifen | 2011 |
Subamolide A, a component isolated from Cinnamomum subavenium, induces apoptosis mediated by mitochondria-dependent, p53 and ERK1/2 pathways in human urothelial carcinoma cell line NTUB1.
Topics: 4-Butyrolactone; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Carcinoma; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cell Survival; Cinnamomum; Cisplatin; Cytochromes c; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Flow Cytometry; Gemcitabine; Humans; Membrane Potential, Mitochondrial; Mitochondria; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Plant Preparations; Plant Stems; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Signal Transduction; Time Factors; Tumor Suppressor Protein p53; Urologic Neoplasms; Urothelium | 2011 |
Mechanisms of TRAIL and gemcitabine induction of pancreatic cancer cell apoptosis.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Deoxycytidine; Down-Regulation; Gemcitabine; Humans; Intracellular Signaling Peptides and Proteins; Mitochondrial Proteins; Pancreatic Neoplasms; TNF-Related Apoptosis-Inducing Ligand; Up-Regulation; X-Linked Inhibitor of Apoptosis Protein | 2011 |
LCL124, a cationic analog of ceramide, selectively induces pancreatic cancer cell death by accumulating in mitochondria.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Benzimidazoles; Blotting, Western; Carbocyanines; Cell Death; Cell Line, Tumor; Ceramides; Chromatography, High Pressure Liquid; Coloring Agents; Cytochromes c; Deoxycytidine; Female; Gemcitabine; Membrane Potential, Mitochondrial; Mice; Mice, Nude; Mitochondria; Oxygen Consumption; Pancreatic Neoplasms; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spectrum Analysis; Xenograft Model Antitumor Assays | 2013 |
Andrographolide causes apoptosis via inactivation of STAT3 and Akt and potentiates antitumor activity of gemcitabine in pancreatic cancer.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Apoptosis; Blotting, Western; Cell Count; Cell Cycle; Cell Line, Tumor; Coloring Agents; Cytochromes c; Deoxycytidine; Diterpenes; Drug Synergism; Flow Cytometry; Gemcitabine; Gentian Violet; Humans; Ki-67 Antigen; Male; Mice; Mice, Inbred BALB C; Pancreatic Neoplasms; Proto-Oncogene Proteins c-akt; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2013 |
Simultaneous knock-down of Bcl-xL and Mcl-1 induces apoptosis through Bax activation in pancreatic cancer cells.
Topics: Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Caspases; Cell Line, Tumor; Cytochromes c; Deoxycytidine; Enzyme Activation; Gemcitabine; Gene Knockdown Techniques; Humans; Mitochondria; Myeloid Cell Leukemia Sequence 1 Protein; Pancreatic Neoplasms | 2013 |
Enhancement of the effects of gemcitabine against pancreatic cancer by oridonin via the mitochondrial caspase-dependent signaling pathway.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Deoxycytidine; Diterpenes, Kaurane; Drug Synergism; G1 Phase Cell Cycle Checkpoints; Gemcitabine; Humans; Mitochondria; Pancreatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Signal Transduction | 2014 |